Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

155.01
Delayed Data
As of May 26
 -0.42 / -0.27%
Today’s Change
133.64
Today|||52-Week Range
184.21
+6.02%
Year-to-Date
Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote
May 26 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers
May 24 / Zacks.com - Paid Partner Content
Hm Payson & Co Buys Amgen Inc, Adient PLC, iShares Russell 2000, Sells Johnson Contro...
May 25 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data
May 24 / Zacks.com - Paid Partner Content
Radius Health Osteoporosis Drug Positive in Phase III Study
May 25 / Zacks.com - Paid Partner Content
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna
May 23 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene
May 25 / Zacks.com - Paid Partner Content
Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab
May 22 / Zacks.com - Paid Partner Content
Third Avenue Continues to Buy Amgen, 8 Others
May 24 / GuruFocus News - Paid Partner Content
Osteoporosis Drug Meets Primary and Secondary Endpoints
May 22 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close155.43
Today’s open155.60
Day’s range154.79 - 156.13
Volume2,731,557
Average volume (3 months)3,613,810
Market cap$114.0B
Dividend yield2.97%
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+6.82%
Earnings growth (next 5 years)+6.27%
Revenue growth (last year)+6.31%
P/E ratio14.7
Price/Sales4.86
Price/Book3.83

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.06-0.09%
BIIBBiogen-2.17-0.86%
ILMNIllumina Inc+2.15+1.24%
BIVVBioverativ Inc+1.74+3.16%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts